Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acellular pertussis vaccine (Pa)]

W Magdzik1

  • 1Zakład Epidemiologii Państwowego Zakładu Higieny w Warszawie.

Przeglad Epidemiologiczny
|January 1, 1995
PubMed
Summary

Whole-cell pertussis vaccines (Pw) reduced pertussis deaths, but acellular pertussis vaccines (Pa) offer a safer, less reactive alternative. Acellular vaccines are effective for booster doses in children and adults, potentially curbing pertussis spread.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infectious diseases in Poland in 1999].

Przeglad epidemiologiczny·2001
Same author

[The future of epidemiology in Poland in twenty first century. Communicable diseases].

Przeglad epidemiologiczny·2001
Same author

[Spongiform encephalopathy ( prion diseases) in people].

Przeglad epidemiologiczny·2001
Same author

[Spongiform encephalopathy (prion diseases) in animals].

Przeglad epidemiologiczny·2001
Same author

[Eradication, elimination of congenital rubella syndrome].

Ginekologia polska·2001
Same author

[Previous achievements and plan for further action to eradicate poliomyelitis in countries from the European region of the World Health Organization].

Przeglad epidemiologiczny·2001

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Context:

  • Whole-cell pertussis vaccine (Pw) historically reduced pertussis morbidity and mortality.
  • High reactogenicity of Pw prompted research into less reactogenic alternatives.
  • Acellular pertussis vaccine (Pa) emerged as an effective, safer, and less reactogenic option.

Purpose:

  • To evaluate the efficacy and safety of acellular pertussis vaccines (Pa) compared to whole-cell pertussis vaccines (Pw).
  • To explore the role of acellular pertussis vaccines (Pa) in booster doses for older children and adults.
  • To address the increasing pertussis morbidity observed in certain regions.

Summary:

  • Acellular pertussis vaccine (Pa) is effective, safe, and less reactogenic than whole-cell pertussis vaccine (Pw).
  • Pa is suitable for booster doses in older children and adults, who may be sources of pertussis infection for infants.
  • Current trends show increasing pertussis incidence in some areas, necessitating updated vaccination strategies.

Impact:

  • Acellular pertussis vaccines (Pa) can be used for primary vaccination in some countries.
  • Pa introduction as booster doses for 6-7-year-olds may be considered if pertussis epidemiology in school-aged children remains unsatisfactory.
  • Improved pertussis control through safer and effective vaccination strategies.

Related Experiment Videos